Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study

NCT00116090 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00116090
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00116090 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Immunosupressive Therapy for Eye Diseases (SITE) Cohort Study
Lead sponsor
National Eye Institute (NEI)
Phase
Observational
Overall status
Completed
Start date
June 16, 2005
Completion date
April 21, 2008
Enrollment
6,300
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, immunosuppression, infection, mortality, uveitis